CHOP and COG Will Validate New Tool to Measure NF1-Related Progressive Vision Loss
Published on
CHOP researchers will use optical coherence tomography (OCT) to measure vision changes associated with NF1-related optic pathway gliomas.
Published on
CHOP researchers will use optical coherence tomography (OCT) to measure vision changes associated with NF1-related optic pathway gliomas.
Published on
A Phase 2 clinical trial involving CHOP and the Neurofibromatosis Clinical Trials Consortium showed cabozantinib reduced tumor volume and pain.
Published on
New therapy shrinks tumors associated with NF1 and improves quality of life.
Published on
Children’s Hospital of Philadelphia’s sixth annual Cheers for CHOP raised $735,000 to support pediatric brain tumor research and care.
Published on
The Healthcare Hero in the field of Cancer was awarded to Phillip “Jay” Storm, MD, for his transformative work in pediatric brain tumor research and care.
Published on
Proton therapy at CHOP helped Elena regain her vision and remain free of craniopharyngioma two years after treatment.
Published on
Learn about CHOP's goal to develop improved, less toxic therapies for pediatric brain tumors by integrating neuro-oncology, neurosurgery, research and big data.
Published on
Watch this video segment to learn about advances in pediatric brain tumor treatments and research at Children’s Hospital of Philadelphia.
Published on
Children's Hospital of Philadelphia and World Poker Tour Foundation raise more than $812,000 at annual event to help advance CHOP’s brain tumor research.
Published on
Researchers have found key differences among the most common types of pediatric brain tumors that may lead to more effective therapy.